Targets and strategies for vaccine development against dengue viruses
Dengue virus (DENV) is a global health threat causing about half of the worldwide population to be at risk of infection, especially the people living in tropical and subtropical area. Although the dengue disease caused by dengue virus (DENV) is asymptomatic and self-limiting in most people with firs...
Guardado en:
Autores principales: | Wen-Hung Wang, Aspiro Nayim Urbina, Chih-Yen Lin, Zih-Syuan Yang, Wanchai Assavalapsakul, Arunee Thitithanyanont, Po-Liang Lu, Yen-Hsu Chen, Sheng-Fan Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b82ac87f0794d5397fcf64639058fce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Developing a Stabilizing Formulation of a Live Chimeric Dengue Virus Vaccine Dry Coated on a High-Density Microarray Patch
por: Jovin J. Y. Choo, et al.
Publicado: (2021) -
Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex
por: Emily H. Davis, et al.
Publicado: (2019) -
Regional Variation in Dengue Virus Serotypes in Sri Lanka and Its Clinical and Epidemiological Relevance
por: Tibutius T. P. Jayadas, et al.
Publicado: (2021) -
Viremia en plasma como factor asociado a gravedad en la infección por el virus del dengue: revisión sistemática de la literatura
por: Gómez-Ochoa,Sergio Alejandro
Publicado: (2018) -
Recent Progress in <i>Shigella</i> and <i>Burkholderia pseudomallei</i> Vaccines
por: Itziar Chapartegui-González, et al.
Publicado: (2021)